Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Envisagenics

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

PAO-09-23-RT-02September 15, 2023

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

PAO-07-23-RT-01July 21, 2023

How is an increased focus on patient-centric concerns influencing the way that you work?

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

PAO-07-23-RT-02July 21, 2023

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Martin Akerman, Ph.D.

Envisagenics

PAO-02-23-CL-08April 12, 2023

Leveraging AI and RNA to Fight Rare Diseases

Rare Diseases

Leveraging AI and RNA to Fight Rare Diseases

Envisagenics

PAO-02-22-R250-17February 24, 2022